跳至主要内容
临床试验/NCT07643610
NCT07643610招募中不适用

BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 8,000 人开始时间: 2025年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
8,000
试验地点
1

研究概览

简要总结

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
  • Age ≥18 years
  • Provision of written ICF
  • Clinical diagnosis of cardiogenic shock.
  • impaired organ perfusion due to primary cardiac dysfunction,
  • persistent systolic blood pressure (SBP) <90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
  • evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
  • Cold or clammy extremities
  • Altered mental status
  • Reduced urine output
  • Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
  • Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded

排除标准

  • Age <18 years
  • Refusal to provide informed consent by the patient or their legally authorized representative

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验